Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy.
Ayelet Snir(Technion – Israel Institute of Technology), Elias Toubi(Bnai Zion Medical Center), Gleb Slobodin(Bnai Zion Medical Center), Tharwat Haj(Technion – Israel Institute of Technology), Aharon Kessel(Technion – Israel Institute of Technology), Inger L. Rosner
PubMed
November 1, 2011
Cited by 48
Related Papers
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.4k
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k